Measurable Residual Disease by Next-Generation Flow Cytometry in Multiple MyelomaBruno Paiva, Laura Rosiñol, Lourdes Cordón et al.|Journal of Clinical Oncology|2019Cited by 279
Bortezomib, lenalidomide, and dexamethasone as induction therapy prior to autologous transplant in multiple myelomaLaura Rosiñol, Joan Bladé, Albert Oriol et al.|Blood|2019Cited by 218